Table 2.
Key features of pulmonary histoplasmosis.
Clinical Form | ||||
---|---|---|---|---|
Characteristic | Acute | Subacute | Nodular | Chronic Cavitary |
Age | Any | Any | Any | >50-year-old with structural lung disease |
Clinical manifestation | Fever, headache, dry cough, chills, chest pain, malaise, myalgias and arthritis | Same as acute but symptoms are milder | Usually asymptomatic | Fever, productive cough, dyspnea, weight loss, hemoptysis, night sweats, chest pain |
Symptom duration | 1–2 weeks | Weeks to months | - | Months to years |
Mimicked disease | Community acquired pneumonia | Community acquired pneumonia | Neoplasm | Tuberculosis, Sarcoidosis |
Pathology | Granuloma with acute lung injury | Well-formed granulomas | Well-formed granulomas | Cavities with granulomas, tissue destruction |
Radiologic findings | Diffuse bilateral patchy opacities | Focal or patchy opacities | Nodules | Cavitation, fibrosis, volume loss, pleural thickening. Right upper lobe is most commonly affected |
Hilar and Mediastinal lymph nodes | Enlarged | Enlarged | Not enlarged | Not enlarged. Occasionally calcified |
Calcifications | None | None | Present | Present |
Indications for treatment | Severe disease | Symptoms over 1 month | None | Yes |